Evaluation of thrombopoiesis kinetics by measurement of reticulated platelets and CD34+ cell subsets in patients with solid tumors following high dose chemotherapy and autologous peripheral blood progenitor cell support

Haematologica

Volumn 86, Issue 9, 2001, Pages 959-964

  Consolini, R ^a   Calleri, A ^a   Bengala, C ^a   Legitimo, A ^a   Conte, P F ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

CD34+; Cell subsets; Peripheral blood progenitor cell transplantation; Reticulated platelets; Thrombopoiesis

Indexed keywords

CD34 ANTIGEN; CD61 ANTIGEN; IDARUBICIN; MELPHALAN; THIOTEPA;

ADULT; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; SOLID TUMOR; STEM CELL TRANSPLANTATION; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; GRAFT SURVIVAL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KINETICS; MIDDLE AGED; NEOPLASMS; PLATELET COUNT; TRANSPLANTATION, AUTOLOGOUS;

EID: 0034786548     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hematopoietic rescue after high dose chemotherapy using autologous peripheral blood progenitor cells or bone marrow. A randomised comparison
2. Randomised trial of filgrastim mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients
3. Factor influencing platelet recovery after blood cell transplantation in multiple myeloma
4. Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation
5. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis
6. Reticulated platelet counts in the diagnosis of acute immune thrombocytopenic purpura
7. Quantitation of reticulated platelets: Methodology and clinical application
8. Measurement of reticulated platelets following peripheral blood progenitor cell and bone marrow transplantation: Implications for marrow reconstitution and the use of thrombopoietin
9. Flowcytometry to estimate circulating hematopoietic progenitors for autologous transplantation: Comparative analysis of different CD34 monoclonal antibodies
10. + cell enumeration in blood and leukapheresis products: Report from the second Nordic workshop
11. + estimation in peripheral blood for autografting in patients with cancer
12. Cytofluorimetric analysis of CD34 cells
13. + hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation
14. Reticulated platelets count: Metodology and clinical applications
15. Flow cytometric analysis of reticulated platelets: Evidence for a large proportion of non-specific labelling of dense granules by fluorescent dyes
16. Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy
17. The role of anticoagulation in the measurement of platelet volumes
18. Electronically determinated platelet indices in thrombocytopenic patients
19. Heterogeneity of human whole blood platelet subpopulations. 1. Relationship between buoyant density, cell volume, and ultrastructure
20. Evidence that platelet density and volume are not related to aging
21. Measurement of the density of human platelets and its relationship to volume
22. Mean platelet volume: The need for a reference method
23. The diagnostic approach to to the bleeding disorders
24. Platelet dynamics
25. Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: An aid in assessing marrow recovery
26. Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets
27. Thrombopoietin combined with early-acting growth factors effectively expands human hematopoietic progenitor cells in vitro